Baricitinib for the treatment of COVID-19

Austrian Institute for Health Technology Assessment (AIHTA)
Record ID 32018001197
English
Authors' objectives: The aim of this EUnetHTA Rolling Collaborative Review is  to inform health policy at the national/regional and at the European level at an early stage in the life-cycle of therapies which interventions are currently undergoing clinical trials,  to monitor (ongoing studies and their results) permanently - in the format of a Living Document - potential therapies against covid-19,  to present comparative data on effectiveness and safety of potential therapies and  to support preparations for an evidence-based purchasing of regional/ national health politicians, if necessary. To avoid redundancies and duplication, the EUnetHTA Rolling Collaborative Review will reuse sources from international initiatives to collect information and data on Covid-19 treatments.
Details
Project Status: Completed
URL for project: https://eunethta.eu/rcr18/
Year Published: 2021
URL for published report: https://eunethta.eu/rcr18/
Requestor: HTA agencies
English language abstract: An English language summary is available
Publication Type: Rapid Review
MeSH Terms
  • COVID-19
  • SARS-CoV-2
  • Coronavirus Infections
  • Antiviral Agents
  • Azetidines
  • Drug Therapy
Contact
Organisation Name: European Network for Health Technology Assessment
Contact Email: eunethta@zinl.nl
Copyright: CC-BY-NC: You may copy, distribute, display, perform, and modify and use the EUnetHTA work for any purpose other than commercially unless you get your permission first.
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.